Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Policy & Regulation
Trends & Finance
Guideline: Page 2
NCI study outlines challenges, opportunities in achieving Cancer Moonshot goals
By
Elissa Wolfson
A National Cancer Institute study outlined challenges and opportunities in achieving President Biden’s Cancer Moonshot goal -- a 50% reduction in U.S. cancer death rates by 2047.
April 18, 2023
Report identifies bias factors in clinical genetic testing
By
Nick Paul Taylor
ACMG committees worked together on a points-to-consider report in light of the potential for clinical, technical, and environmental biases to influence equitable access to clinical genetics testing.
April 14, 2023
AACC provides recommendations for detecting cervical cancer
By
LabPulse.com staff writers
The guidance aims to update healthcare and laboratory medicine professionals about the latest advancements in this field, and to help them select the most effective cervical cancer detection strategy for their patients, AACC said.
March 6, 2023
Agendia MammaPrint UltraLow Risk gene signature recognized in updated NCCN guidelines
By
LabPulse.com staff writers
The MammaPrint 70-gene signature identifies patients at low or high risk of distant recurrence within five years of a breast cancer diagnosis.
February 13, 2023
Study suggests race adjustment unnecessary for alpha fetoprotein prenatal testing
By
Elissa Wolfson
Researchers recommend that a longstanding race-based adjustment to test-result values of alpha fetoprotein from a common prenatal screening should be discontinued.
February 6, 2023
OIG report outlines challenges with CDC-supported COVID-19 vaccination programs
By
Leo O'Connor
There were challenges with "vaccine logistics, such as large minimum order sizes for vaccines, requirements for ultra-cold storage, and insufficient ancillary supplies," OIG said.
January 31, 2023
Natera announces results for NIPT in twin-pregnancy clinical study
By
LabPulse.com staff writers
Using single-nucleotide polymorphism technology, the test analyzes fetal DNA obtained through a blood draw from the mother.
December 7, 2022
Stop: Don't order these tests
By
LabPulse.com staff writers
Industry organizations have collaborated on recommendations to ensure patients receive the right testing at the right time.
November 8, 2022
FDA proposes updates to breakthrough devices guidance focused on reducing disparities in healthcare
By
LabPulse.com staff writers
The agency is proposing updates to clarify considerations in designating devices, including eligible devices that may benefit populations impacted by disparities in healthcare.
October 20, 2022
Exact Sciences awards $525K in grants to improve CRC screening
By
LabPulse.com staff writers
Exact's Funding Opportunities for CRC Screening Uptake Strategies (FOCUS) program provided the grant funding. Awardees will use the funds to implement evidence-based and informed intervention strategies proven to increase colorectal cancer screening rates, the firm said.
September 21, 2022
USPSTF: more evidence needed on diabetes screening
By
LabPulse.com staff writers
The Task Force concluded that more research is needed to recommend for or against screening children and adolescents without signs or symptoms.
September 12, 2022
Week in Review: Roche’s new MDx system, HIV world market, cervical cancer testing disparities, and more
By
Leo O'Connor
Dear LabPulse.com member,
August 24, 2022
Previous Page
Page 2 of 9
Next Page
